XML 20 R6.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Common Stock
Common Class A
Previously Reported
Common Stock
Common Class A
Revision of Prior Period, Adjustment
Common Stock
Common Class A
Common Stock
Previously Reported
 [1]
Common Stock
Revision of Prior Period, Adjustment
 [1]
Common Stock
Additional Paid-in Capital
Previously Reported
Additional Paid-in Capital
Revision of Prior Period, Adjustment
Additional Paid-in Capital
Accumulated Deficit
Previously Reported
Accumulated Deficit
Revision of Prior Period, Adjustment
Accumulated Deficit
Accumulated Other Comprehensive Income
Previously Reported
Accumulated Other Comprehensive Income
Revision of Prior Period, Adjustment
Accumulated Other Comprehensive Income
Common Class A
Previously Reported
Revision of Prior Period, Adjustment
Total
Balance as of beginning of period (in shares) at Dec. 31, 2022                                 6,585,881 (6,585,881) 0
Balance as of beginning of period at Dec. 31, 2022                                 $ 25,032 $ (25,032) $ 0
Balance as of end of period (in shares) at Dec. 31, 2023                                     0
Balance as of end of period at Dec. 31, 2023                                     $ 0
Common stock, outstanding balance as of beginning of the period (in shares) at Dec. 31, 2022 0 68,845,564 68,845,564 4,771,025 (4,771,025) 0 [1]                          
Equity, balance as of beginning of the period at Dec. 31, 2022 $ 0 $ 7 $ 7 $ 0 $ 0 $ 0 [1] $ 1,209 $ 25,025 $ 26,234 $ (29,320) $ 0 $ (29,320) $ 0 $ 0 $ 0   $ (28,111) $ 25,032 (3,079)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                      
Exercise of stock options (in shares)     397,376                         397,376      
Exercise of stock options                 114             $ 114     114
Stock-based compensation                 777                   777
Change in unrealized gains on marketable debt securities                                     0
Net loss                       (32,173)             $ (32,173)
Common stock, outstanding balance as of end of period (in shares) at Dec. 31, 2023     69,242,940     0 [1],[2]                         69,242,940
Equity, balance as of end of period at Dec. 31, 2023     $ 7     $ 0 [1],[2]     27,125     (61,493)     0       $ (34,361)
Balance as of end of period (in shares) at Dec. 31, 2024                                     0
Balance as of end of period at Dec. 31, 2024                                     $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                      
Exercise of stock options (in shares)     2,256,157                         2,256,157     2,256,157
Exercise of stock options                 1,044             $ 1,044     $ 1,044
Stock-based compensation                 12,484                   12,484
Issuance of Class A common stock in connection with the Business Combination, net of transaction costs (Note 3) (in shares)     43,099,811                                
Issuance of Class A common stock in connection with the Business Combination, net of transaction costs (Note 3)     $ 4           258,951                   258,955
Issuance of Class A common stock upon conversion of simple agreements for future equity immediately before the Business Combination (Note 3) (in shares)     8,407,894                                
Issuance of Class A common stock upon conversion of simple agreements for future equity immediately before the Business Combination (Note 3)     $ 1           84,137                   84,138
Change in unrealized gains on marketable debt securities                             2,213       2,213
Issuance of Class A common stock in connection with earnout awards (in shares)     14,699,794                                
Issuance of Class A common stock in connection with earnout awards     $ 2           (2)                   0
Net loss                       (73,616)             $ (73,616)
Common stock, outstanding balance as of end of period (in shares) at Dec. 31, 2024     137,706,596     0 [2]                         137,706,596
Equity, balance as of end of period at Dec. 31, 2024     $ 14     $ 0 [2]     $ 383,739     $ (135,109)     $ 2,213       $ 250,857
[1] The shares of the Company’s common stock prior to the reverse recapitalization have been retrospectively recast to reflect the change in the capital structure as a result of the Business Combination as described in Note 3.
[2] The shares of the Company’s common stock prior to the Business Combination (as defined below) have been retrospectively recast to reflect the change in the capital structure as a result of the Business Combination as described in Note 3.